Neuropsychiatric background of alcohol hallucinosis: A SPECT study [2]

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 19, Issue 1, 2007, Pages 85-

  Kitabayashi, Yurinosuke ^a   Narumoto, Jin ^a   Shibata, Keisuke ^a   Ueda, Hideki ^a   Fukui, Kenji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DIAZEPAM; HALOPERIDOL; IOFETAMINE I 123;

ADULT; ALCOHOL ABUSE; ALCOHOL HALLUCINOSIS; BASAL GANGLION; BRAIN BLOOD FLOW; CASE REPORT; CLINICAL FEATURE; DELUSION; DRUG DOSE REDUCTION; FRONTAL LOBE; HALLUCINOSIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

EID: 33847150172     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2007.19.1.85     Document Type: Letter

References (4)

1. Moselhy HF, Georgiou G, Kahn A: Frontal lobe changes in alcoholism: a review of the literature. Alcohol 2001; 36:357-368
2. Sabri O, Erkwoh R, Schreckenberger M, et al: Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet 1997; 349:1735-1739
3. Soyka M, Dresel S, Horak M, et al: PET and SPECT findings in alcohol hallucinosis: case report and super-brief review of the pathophysiology of this syndrome. World J Biol Psychiatry 2000; 1:215-218
4. Soyka M, Zetzsche T, Dresel S, et al: FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis. J Neuropsychiatry Clin Neurosci 2000; 12:287-288